Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Critical Reagent ProcessingFRA:DV4 32 EBIT per Share is €-0.04 as of Mar. 2026. GuruFocus rates FRA:DV4 with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 2,181 Metals & Mining companies, Critical Reagent Processing ranks better than 87.85% on this metric.
Critical Reagent Processing's EBIT per Share for the
three
months ended in Mar. 2026 was €-0.01.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.04.
During the past 3 years, the average EBIT per Share Growth Rate was 48.60% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 45.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Critical Reagent Processing's EBIT per Share or its related term are showing as below:
FRA:DV4'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 19 Med: 45.9 Max: 58.9
Current: 48.6
During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of Critical Reagent Processing was 58.90% per year. The lowest was 19.00% per year. And the median was 45.90% per year.
FRA:DV4's 3-Year EBIT Growth Rate is ranked better than 87.85% of 2181
companies
in the Metals & Mining industry
Industry Median: 16.3
vs FRA:DV4: 48.60
Critical Reagent Processing (FRA:DV4) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Critical Reagent Processing EBIT per Share Related Terms
Critical Reagent Processing EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Critical Reagent Processing (FRA:DV4) has a EBIT per Share of €-0.04 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Critical Reagent Processing and its competitors. According to the industry distribution chart, Critical Reagent Processing ranks #265 out of 2181 companies in the Metals & Mining industry, placing it in the top 12.2%.
Is Critical Reagent Processing's EBIT per Share too high?
Critical Reagent Processing's current EBIT per Share is €-0.04. Based on the distribution chart, Critical Reagent Processing ranks #265 out of 2181 companies in the Metals & Mining industry, which is in the top quartile — a strong position relative to peers. Overall, Critical Reagent Processing has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Critical Reagent Processing's EBIT per Share compare to NEM and AU?
According to the Metals & Mining industry distribution chart, Critical Reagent Processing ranks #265 out of 2181 companies for EBIT per Share. This places Critical Reagent Processing in the top 12% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 16.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Metals & Mining company?
The median EBIT per Share among Metals & Mining companies is 16.30, based on 2,181 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Critical Reagent Processing and its competitors. For the Metals & Mining industry, the median EBIT per Share is 16.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Critical Reagent Processing's current EBIT per Share is €-0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Critical Reagent Processing stock overvalued right now?
Critical Reagent Processing (FRA:DV4) has a current EBIT per Share of €-0.04. The current EBIT per Share is €-0.04. Critical Reagent Processing's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Critical Reagent Processing (FRA:DV4), the current EBIT per Share is €-0.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Critical Reagent Processing Corp is engaged in the acquisition and exploration of mineral properties in Canada. The company explores gold and sodium carbonate. The projects of the company include Laguna Santa Maria Project. The project is comprised of two mining concessions which total 500 hectares. It earns maximum revenue from Argentina.
32GF Score
Get the complete analysis for FRA:DV4
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:DV4 has been successfully added to your 
